Impact of a pharmacist-directed heparin-induced thrombocytopenia service on the appropriateness of treatment and drug costs

被引：0
|
作者：
Torppey, Kayla [1 ]
Patel, Sheetal [1 ]
Kansagra, Leena [1 ]
机构：
[1] Newark Beth Israel Med Ctr, Dept Pharm, Newark, NJ USA
来源：
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
179
引用
收藏
页码：E175 / E175
页数：1
相关论文
共 50 条
  • [41] Dabigatran as a Treatment Option for Heparin-Induced Thrombocytopenia
    Nasiripour, Somayyeh
    Saif, Maryam
    Farasatinasab, Maryam
    Emami, Sepide
    Amouzegar, Atefeh
    Basi, Ali
    Mokhtari, Majid
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (01): : 107 - 111
  • [42] New treatment options for heparin-induced thrombocytopenia
    Ortel, TL
    Chong, BH
    SEMINARS IN HEMATOLOGY, 1998, 35 (04) : 26 - 34
  • [43] Heparin-induced thrombocytopenia - Pathogenesis, diagnosis and treatment
    Gruel, Y
    REVUE DE MEDECINE INTERNE, 2004, 25 (01): : 35 - 45
  • [44] Bivalirudin treatment of heparin-induced thrombocytopenia.
    Berilgen, JE
    Nguyen, PH
    Baker, KR
    Rice, L
    BLOOD, 2003, 102 (11) : 537A - 537A
  • [45] Current treatment concepts for heparin-induced thrombocytopenia
    Ranze, O
    Greinacher, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (28-29) : 865 - 873
  • [46] Acute apixaban treatment of heparin-induced thrombocytopenia
    Delgado-Garcia, Guillermo
    Monreal-Robles, Roberto
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (03) : 289 - 290
  • [47] Acute apixaban treatment of heparin-induced thrombocytopenia
    Guillermo Delgado-García
    Roberto Monreal-Robles
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 289 - 290
  • [48] Heparin-induced thrombocytopenia: Recognition, treatment, and prevention
    Warkentin, TE
    Greinacher, A
    CHEST, 2004, 126 (03) : 311S - 337S
  • [49] Newer strategies for the treatment of heparin-induced thrombocytopenia
    Warkentin, TE
    Barkin, RL
    PHARMACOTHERAPY, 1999, 19 (02): : 181 - 195
  • [50] The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia
    Natasha Nanwa
    Nicole Mittmann
    Sandra Knowles
    Claudia Bucci
    Rita Selby
    Neil Shear
    Scott E. Walker
    William Geerts
    PharmacoEconomics, 2011, 29 : 511 - 520
12345